Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mangalam Drugs and Organics Limited has informed the stock exchanges that the trading window for dealing in its securities will be closed for designated persons and their immediate relatives starting April 1, 2026. The window will remain shut until 48 hours after the company declares its annual audited financial results for the financial year ending March 31, 2026. This is a standard compliance measure under SEBI's insider trading regulations to prevent trading on unpublished price-sensitive information. The communication was signed by Chairman and Managing Director Govardhan M. Dhoot.
This is a routine regulatory filing and does not affect ordinary retail investors. Designated insiders cannot trade in the stock during this period, but the announcement itself is not material to the stock price or shareholder value.